This transformation markedly downregulated pro-tumoral molecules, including TGF-β, vascular endothelial growth factor (VEGF)-A, and MMP-9, resulting in the suppression of tumor cell growth and metastasis, as well as a notable reduction in xenograft tumor growth in vivo(46). The gene discussed is TGFB1; the disease is neoplasm.